Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 75 articles:
HTML format
Text format



Single Articles


    May 2017
  1. MOSTOFSKY E, Berg Johansen M, Tjonneland A, Chahal HS, et al
    Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study.
    Heart. 2017 May 23. pii: heartjnl-2016-310357. doi: 10.1136/heartjnl-2016-310357
    PubMed     Text format     Abstract available


  2. POKORNEY SD, Piccini JP
    Chocolate and prevention of atrial fibrillation: what is bad for the pancreas might be good for the atria?
    Heart. 2017 May 23. pii: heartjnl-2016-311026. doi: 10.1136/heartjnl-2016-311026
    PubMed     Text format    


  3. GALLAGHER C, Elliott AD, Wong CX, Rangnekar G, et al
    Integrated care in atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2017 May 10. pii: heartjnl-2016-310952. doi: 10.1136/heartjnl-2016-310952
    PubMed     Text format     Abstract available


    April 2017
  4. POTPARA TS, Blomstrom-Lundqvist C
    Sex-related differences in atrial fibrillation: can we discern true disparities from biases?
    Heart. 2017 Apr 29. pii: heartjnl-2016-311085. doi: 10.1136/heartjnl-2016-311085
    PubMed     Text format    


  5. MINAMI Y, Hagiwara N
    Enlarged left atrium, atrial fibrillation and adverse outcome in hypertrophic cardiomyopathy: is there a difference between apical and non-apical phenotype?
    Heart. 2017 Apr 28. pii: heartjnl-2017-311501. doi: 10.1136/heartjnl-2017-311501
    PubMed     Text format    


  6. LEE SE, Park JK, Uhm JS, Kim JY, et al
    Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Heart. 2017 Apr 20. pii: heartjnl-2016-310720. doi: 10.1136/heartjnl-2016-310720
    PubMed     Text format     Abstract available


  7. LIN WS, Lin TC, Hung Y, Lin WY, et al
    Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2016-310451. doi: 10.1136/heartjnl-2016-310451.
    PubMed     Text format     Abstract available


  8. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed     Text format    


    March 2017
  9. ISHIBASHI K, Aiba T, Kamiya C, Miyazaki A, et al
    Arrhythmia risk and beta-blocker therapy in pregnant women with long QT syndrome.
    Heart. 2017 Mar 14. pii: heartjnl-2016-310617. doi: 10.1136/heartjnl-2016-310617
    PubMed     Text format     Abstract available


  10. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Text format     Abstract available


  11. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    PubMed     Text format     Abstract available


  12. VOUKALIS C, Lip GY
    Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
    Heart. 2017 Mar 3. pii: heartjnl-2017-311162. doi: 10.1136/heartjnl-2017-311162.
    PubMed     Text format    


  13. SVENNBERG E, Henriksson P, Engdahl J, Hijazi Z, et al
    N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310236. doi: 10.1136/heartjnl-2016-310236.
    PubMed     Text format     Abstract available


    February 2017
  14. SCHNABEL RB, Pecen L, Ojeda FM, Lucerna M, et al
    Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation.
    Heart. 2017 Feb 22. pii: heartjnl-2016-310406. doi: 10.1136/heartjnl-2016-310406
    PubMed     Text format     Abstract available


  15. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Text format     Abstract available


    January 2017
  16. KIRCHHOF P
    Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines.
    Heart. 2017 Jan 11. pii: heartjnl-2016-310843. doi: 10.1136/heartjnl-2016-310843
    PubMed     Text format    


  17. BLACK-MAIER E, Piccini JP
    Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Heart. 2017 Jan 9. pii: heartjnl-2016-310540. doi: 10.1136/heartjnl-2016-310540.
    PubMed     Text format    


  18. ALONSO A, MacLehose RF, Chen LY, Bengtson LG, et al
    Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.
    Heart. 2017 Jan 5. pii: heartjnl-2016-310586. doi: 10.1136/heartjnl-2016-310586.
    PubMed     Text format     Abstract available


    November 2016
  19. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Text format     Abstract available


    October 2016
  20. GUTTMANN OP, Pavlou M, O'Mahony C, Monserrat L, et al
    Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
    Heart. 2016 Oct 28. pii: heartjnl-2016-309672. doi: 10.1136/heartjnl-2016-309672
    PubMed     Text format     Abstract available


  21. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Text format     Abstract available


  22. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


  23. SVENNBERG E, Engdahl J
    Why should we screen for atrial fibrillation?
    Heart. 2016 Oct 12. pii: heartjnl-2016-310305. doi: 10.1136/heartjnl-2016-310305
    PubMed     Text format    


  24. CHAN NY, Choy CC
    Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram.
    Heart. 2016 Oct 12. pii: heartjnl-2016-309993. doi: 10.1136/heartjnl-2016-309993
    PubMed     Text format     Abstract available


  25. RAHIMI K, Otto CM
    Heartbeat: Is atrial fibrillation ablation effective in patients with hypertrophic cardiomyopathy?
    Heart. 2016;102:1511-2.
    PubMed     Text format    


    September 2016
  26. HEIDBUCHEL H
    The search for the tipping point on when to anticoagulate patients with atrial fibrillation.
    Heart. 2016 Sep 20. pii: heartjnl-2016-310325. doi: 10.1136/heartjnl-2016-310325
    PubMed     Text format    


  27. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Text format     Abstract available


  28. SWAANS MJ, Boersma LV
    Atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Heart. 2016 Sep 13. pii: heartjnl-2016-310198. doi: 10.1136/heartjnl-2016-310198
    PubMed     Text format    


  29. MAZUREK M, Lip GY
    To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Heart. 2016 Sep 12. pii: heartjnl-2016-310255. doi: 10.1136/heartjnl-2016-310255
    PubMed     Text format    


  30. LIND L, Sundstrom J, Stenemo M, Hagstrom E, et al
    Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
    Heart. 2016 Sep 8. pii: heartjnl-2016-309764. doi: 10.1136/heartjnl-2016-309764.
    PubMed     Text format     Abstract available


  31. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Text format     Abstract available


    August 2016
  32. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Text format     Abstract available


  33. NIELSEN JC, Johannessen A, Raatikainen P, Hindricks G, et al
    Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Heart. 2016 Aug 26. pii: heartjnl-2016-309781. doi: 10.1136/heartjnl-2016-309781
    PubMed     Text format     Abstract available


  34. AKOUM N
    New perspectives on atrial fibrillation and stroke.
    Heart. 2016 Aug 24. pii: heartjnl-2015-309066. doi: 10.1136/heartjnl-2015-309066
    PubMed     Text format     Abstract available


  35. AYABE K, Goto S
    Comparative registries of atrial fibrillation from Japan and the UK: is there a difference between the east and west ends of the Eurasian continent?
    Heart. 2016 Aug 12. pii: heartjnl-2016-310024. doi: 10.1136/heartjnl-2016-310024
    PubMed     Text format    


  36. BUI AH, Roujol S, Foppa M, Kissinger KV, et al
    Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309303. doi: 10.1136/heartjnl-2016-309303
    PubMed     Text format     Abstract available


  37. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Text format     Abstract available


    June 2016
  38. PRUTKIN JM, Owens DS
    Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Heart. 2016 Jun 22. pii: heartjnl-2016-309761. doi: 10.1136/heartjnl-2016-309761
    PubMed     Text format    


  39. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Text format     Abstract available


  40. LILLO-CASTELLANO JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, et al
    Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator.
    Heart. 2016 Jun 13. pii: heartjnl-2016-309295. doi: 10.1136/heartjnl-2016-309295
    PubMed     Text format     Abstract available


  41. KHAIRY P
    Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Heart. 2016 Jun 1. pii: heartjnl-2015-309069. doi: 10.1136/heartjnl-2015-309069.
    PubMed     Text format     Abstract available


  42. GUNGOR B
    Obesity and atrial fibrillation: can adipokines help to solve this puzzle.
    Heart. 2016 Jun 1. pii: heartjnl-2016-309751. doi: 10.1136/heartjnl-2016-309751.
    PubMed     Text format    


    May 2016
  43. PROVIDENCIA R, Elliott P, Patel K, McCready J, et al
    Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Heart. 2016 May 27. pii: heartjnl-2016-309406. doi: 10.1136/heartjnl-2016-309406
    PubMed     Text format     Abstract available


  44. ERMAKOV S, Azarbal F, Stefanick ML, LaMonte MJ, et al
    The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
    Heart. 2016 May 4. pii: heartjnl-2015-308927. doi: 10.1136/heartjnl-2015-308927.
    PubMed     Text format     Abstract available


  45. OTTO CM
    Heartbeat: Detection of arrhythmias in older adults with falls and syncope.
    Heart. 2016;102:651-2.
    PubMed     Text format    


  46. GROSSMAN SA
    Dysrhythmia and occult syncope as an explanation for falls in older patients.
    Heart. 2016;102:657.
    PubMed     Text format    


  47. KWOK CS, Rashid M, Beynon R, Barker D, et al
    Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis.
    Heart. 2016;102:672-80.
    PubMed     Text format     Abstract available


  48. BHANGU J, McMahon CG, Hall P, Bennett K, et al
    Long-term cardiac monitoring in older adults with unexplained falls and syncope.
    Heart. 2016;102:681-6.
    PubMed     Text format     Abstract available


    April 2016
  49. OTTO CM
    Heartbeat: Inflammatory biomarkers in atrial fibrillation.
    Heart. 2016;102:485-6.
    PubMed     Text format    


  50. DE MATTIA L, Calzolari V, Crosato M
    The implantable defibrillator that predicted the future.
    Heart. 2016;102:e2.
    PubMed     Text format    


    March 2016
  51. KAUFMANN PA, Stehli J
    Non-invasive imaging for prediction of ventricular arrhythmias.
    Heart. 2016 Mar 22. pii: heartjnl-2015-309238. doi: 10.1136/heartjnl-2015-309238
    PubMed     Text format    


  52. ARO AL
    First-degree atrioventricular block: risk marker or innocent finding?
    Heart. 2016 Mar 2. pii: heartjnl-2015-309256. doi: 10.1136/heartjnl-2015-309256.
    PubMed     Text format    


  53. KIM HJ, Kim JB, Jung SH, Choo SJ, et al
    Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery.
    Heart. 2016 Mar 2. pii: heartjnl-2015-308482. doi: 10.1136/heartjnl-2015-308482.
    PubMed     Text format     Abstract available


  54. SIEIRA J, Conte G, Ciconte G, de Asmundis C, et al
    Clinical characterisation and long-term prognosis of women with Brugada syndrome.
    Heart. 2016;102:452-8.
    PubMed     Text format     Abstract available


    February 2016
  55. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Text format     Abstract available


  56. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Text format     Abstract available


  57. OKUMURA Y
    Inflammatory biomarkers in atrial fibrillation: are they linked to future outcomes?
    Heart. 2016 Feb 10. pii: heartjnl-2015-309079. doi: 10.1136/heartjnl-2015-309079
    PubMed     Text format    


  58. VILLABLANCA PA, Rao G, Briceno DF, Lombardo M, et al
    Therapeutic hypothermia in ST elevation myocardial infarction: a systematic review and meta-analysis of randomised control trials.
    Heart. 2016 Feb 10. pii: heartjnl-2015-308559. doi: 10.1136/heartjnl-2015-308559
    PubMed     Text format     Abstract available


  59. RIJNIERSE MT, Allaart CP, de Haan S, Harms HJ, et al
    Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
    Heart. 2016 Feb 3. pii: heartjnl-2015-308467. doi: 10.1136/heartjnl-2015-308467.
    PubMed     Text format     Abstract available


  60. HIJAZI Z, Aulin J, Andersson U, Alexander JH, et al
    Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
    Heart. 2016 Feb 2. pii: heartjnl-2015-308887. doi: 10.1136/heartjnl-2015-308887.
    PubMed     Text format     Abstract available


  61. KIZER JR
    Adiponectin and atrial fibrillation in older adults.
    Heart. 2016;102:254.
    PubMed     Text format    


  62. KAWADA T
    Total and high-molecular-weight adiponectin are associated with incident atrial fibrillation.
    Heart. 2016;102:254.
    PubMed     Text format    


  63. ORWAT S, Diller GP, Kempny A, Radke R, et al
    Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot.
    Heart. 2016;102:209-15.
    PubMed     Text format     Abstract available


  64. KUSANO KF, Satomi K
    Diagnosis and treatment of cardiac sarcoidosis.
    Heart. 2016;102:184-90.
    PubMed     Text format     Abstract available


    January 2016
  65. JAWAD-UL-QAMAR M, Kirchhof P
    Almanac 2015: atrial fibrillation research in Heart.
    Heart. 2016 Jan 20. pii: heartjnl-2015-307809. doi: 10.1136/heartjnl-2015-307809
    PubMed     Text format     Abstract available


  66. PRUTKIN JM, Ackerman MJ, Drezner JA
    Athletes with implantable cardioverter defibrillators: can they return to competitive sports?
    Heart. 2016;102:93-4.
    PubMed     Text format    


  67. VALEUR N, Merie C, Hansen ML, Torp-Pedersen C, et al
    Risk of death and stroke associated with anticoagulation therapy after mitral valve repair.
    Heart. 2016 Jan 4. pii: heartjnl-2015-308272. doi: 10.1136/heartjnl-2015-308272.
    PubMed     Text format     Abstract available


  68. AUFFRET V, Loirat A, Leurent G, Martins RP, et al
    High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era.
    Heart. 2016;102:40-9.
    PubMed     Text format     Abstract available


  69. WILLCOX ME, Kudenchuk PJ, Prutkin JM
    Very abnormal T waves in a 37-year-old man.
    Heart. 2016;102:163-4.
    PubMed     Text format    


    December 2015
  70. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


  71. CHIRILLO F, Fusaro M, Morana G, Olivari Z, et al
    An intriguing intracardiac mass in a woman with atrial fibrillation.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308704. doi: 10.1136/heartjnl-2015-308704
    PubMed     Text format    


    November 2015
  72. MAHTANI KR, Nunan D, Heneghan C
    Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
    Heart. 2015;101:1689-90.
    PubMed     Text format    


    October 2015
  73. KUMAR V, Eltelbany M, Fonbah W
    Palpitations in a 46-year-old man.
    Heart. 2015;101:1561.
    PubMed     Text format    


  74. OTTO CM
    Heartbeat: highlights from this issue.
    Heart. 2015;101:1603-4.
    PubMed     Text format    


    August 2015
  75. DIZON JM, Nazif TM, Hess PL, Biviano A, et al
    Chronic pacing and adverse outcomes after transcatheter aortic valve implantation.
    Heart. 2015 Aug 10. pii: heartjnl-2015-307666. doi: 10.1136/heartjnl-2015-307666
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: